Stocks That Hit 52-Week Lows On Wednesday
During Wednesday's trading, 103 companies set new 52-week lows.
12 Health Care Stocks Moving In Thursday’s Pre-Market Session
Gainers HeartBeam (NASDAQ:BEAT) stock rose 20.1% to $2.42 during Thursday’s pre-market session. The company’s market cap stands at…
HC Wainwright & Co. Maintains Buy on Prelude Therapeutics, Raises Price Target to $17
HC Wainwright & Co. analyst Robert Burns maintains Prelude Therapeutics (NASDAQ:PRLD) with a Buy and raises the price target from $15 to $17.
Why Horizon Global Shares Are Trading Higher By Over 340%? Here Are Other Stocks Moving In Tuesday’s Mid-Day Session
Gainers
Horizon Global Corporation (NYSE: HZN) shares surged 341% to $1.7161 after the company announced it will be acquired by First Brands Group.
HC Wainwright & Co. Maintains Buy on Prelude Therapeutics, Lowers Price Target to $15
HC Wainwright & Co. analyst Robert Burns maintains Prelude Therapeutics (NASDAQ:PRLD) with a Buy and lowers the price target from $16 to $15.
Prelude Therapeutics Q3 EPS $(0.63) Up From $(0.66) YoY
Prelude Therapeutics (NASDAQ:PRLD) reported quarterly losses of $(0.63) per share. This is a 4.55 percent increase over losses of $(0.66) per share from the same period last year.